Глюкагонома: важнейшие аспекты диагностики в гастроэнтерологии и дерматологии
Глюкагонома: важнейшие аспекты диагностики в гастроэнтерологии и дерматологии
Материалы доступны только для специалистов сферы здравоохранения. Авторизуйтесь или зарегистрируйтесь.
Аннотация
Список литературы
1. Губергриц Н.Б., Христич Т.Н. Клиническая панкреатология. Донецк: Лебедь, 2000.
2. Маев И.В., Кучерявый Ю.А. Болезни поджелудочной железы. В 2 т. М.: Медицина, 2008.
3. Уголев А.М., Радбиль О.С. Гормоны пищеварительной системы: Физиология, патология, теория функциональных блоков. М.: Наука, 1995.
4. Becker SW, Kahn D, Rothman S. Cutaneous manifestations of internal malignant tumors. Arch Dermatol Syphilol 1942; 45: 1069–80.
5. Boden G, Owen O. Familial hyperglucagonemia – an autosomal dominant disorder. N Engl J Med 1977; 296: 534–8.
6. Boden G, Ryan I, Eisenschmid B et al. Treatment of inoperable glucagonoma with the long-acting somatostatin analogue SMS 201-995. N Engl J Med 1986; 314: 1686–9.
7. Bonaventure C, Merle P, Grezard P et al. Glucagonoma revealed by
necrolytic migratory erythema. Gastroenterol Clin Biol 2003; 27:
230–2.
8. Chu Q, Al-Kasspooles M, Smith J et al. Is glucagonoma of the pancreas a curable disease? Int J Gastrointest Cancer 2001; 29: 155–62.
9. Echenique-Elizondo M, Elorza JL, De Delas JS. Migratory necrolytic erythema and glucagonoma. Surgery 2003; 133: 449–50.
10. Echenique-Elizondo M, Valls AT, Elorza JL et al. Glucagonoma and
Pseudoglucagonoma Syndrome. JOP J Pancreas (Online) 2004; 5 (4):
179–85.
11. Feldman МВ, Toskes РР et al. Gastroenterology and Hepatology: The
Comprehensive Visual Reference – Pancreas, with MEDLINE-Linked References. Electronic Press Ltd, 1996.
12. Fjallskog ML, Sundin A, Westlin JE et al. Treatment of malignant endocrine pancreatic tumors with a combination of alpha-interferon and somatostatin analogs. Med Oncol 2002; 19: 35–42.
13. Le Bodick M, Le Bodick L, Duchesne N et al. Le syndrome de glucagonome. Arch Anat Cyth Pathol 1981; 29: 338–44.
14. Leichter S. Clinical and metabolic aspects of glucagonoma. Medicine 1980; 54: 100–13.
15. MacGavran M, Under R, Recant L et al. A glucagon-secreting alphacell carcinoma of the pancreas. N Engl J Med 1966; 274: 1408–12.
16. Mallinson C, Bloom S, Warin A et al. A glucagonoma syndrome. Lancet 1974; 2: 1–5.
17. Schier J, Janmougin M, Lonbrail Р. Rapid improvement of skin lesions in glucagomas with intravenous somatostatin infusion. Lancet 1980; 1: 40.
18. Thompson N, Eckhauser F. Malignant islet-cell tumors of the pancreas: Ultrastructure and immunochemistry. World J Surg 1984; 8:1–12.
19. Wermers RA, Fatourechi V, Wynne AG et al. The glucagonoma syndrome. Clinical and pathologic features in 21 patients. Medicine (Baltimore) 1996; 75: 53–63.
2. Маев И.В., Кучерявый Ю.А. Болезни поджелудочной железы. В 2 т. М.: Медицина, 2008.
3. Уголев А.М., Радбиль О.С. Гормоны пищеварительной системы: Физиология, патология, теория функциональных блоков. М.: Наука, 1995.
4. Becker SW, Kahn D, Rothman S. Cutaneous manifestations of internal malignant tumors. Arch Dermatol Syphilol 1942; 45: 1069–80.
5. Boden G, Owen O. Familial hyperglucagonemia – an autosomal dominant disorder. N Engl J Med 1977; 296: 534–8.
6. Boden G, Ryan I, Eisenschmid B et al. Treatment of inoperable glucagonoma with the long-acting somatostatin analogue SMS 201-995. N Engl J Med 1986; 314: 1686–9.
7. Bonaventure C, Merle P, Grezard P et al. Glucagonoma revealed by
necrolytic migratory erythema. Gastroenterol Clin Biol 2003; 27:
230–2.
8. Chu Q, Al-Kasspooles M, Smith J et al. Is glucagonoma of the pancreas a curable disease? Int J Gastrointest Cancer 2001; 29: 155–62.
9. Echenique-Elizondo M, Elorza JL, De Delas JS. Migratory necrolytic erythema and glucagonoma. Surgery 2003; 133: 449–50.
10. Echenique-Elizondo M, Valls AT, Elorza JL et al. Glucagonoma and
Pseudoglucagonoma Syndrome. JOP J Pancreas (Online) 2004; 5 (4):
179–85.
11. Feldman МВ, Toskes РР et al. Gastroenterology and Hepatology: The
Comprehensive Visual Reference – Pancreas, with MEDLINE-Linked References. Electronic Press Ltd, 1996.
12. Fjallskog ML, Sundin A, Westlin JE et al. Treatment of malignant endocrine pancreatic tumors with a combination of alpha-interferon and somatostatin analogs. Med Oncol 2002; 19: 35–42.
13. Le Bodick M, Le Bodick L, Duchesne N et al. Le syndrome de glucagonome. Arch Anat Cyth Pathol 1981; 29: 338–44.
14. Leichter S. Clinical and metabolic aspects of glucagonoma. Medicine 1980; 54: 100–13.
15. MacGavran M, Under R, Recant L et al. A glucagon-secreting alphacell carcinoma of the pancreas. N Engl J Med 1966; 274: 1408–12.
16. Mallinson C, Bloom S, Warin A et al. A glucagonoma syndrome. Lancet 1974; 2: 1–5.
17. Schier J, Janmougin M, Lonbrail Р. Rapid improvement of skin lesions in glucagomas with intravenous somatostatin infusion. Lancet 1980; 1: 40.
18. Thompson N, Eckhauser F. Malignant islet-cell tumors of the pancreas: Ultrastructure and immunochemistry. World J Surg 1984; 8:1–12.
19. Wermers RA, Fatourechi V, Wynne AG et al. The glucagonoma syndrome. Clinical and pathologic features in 21 patients. Medicine (Baltimore) 1996; 75: 53–63.
Авторы
Ю.А.Кучерявый
Кафедра пропедевтики внутренних болезней и гастроэнтерологии ГОУ ВПО МГМСУ Росздрава
Кафедра пропедевтики внутренних болезней и гастроэнтерологии ГОУ ВПО МГМСУ Росздрава
Цель портала OmniDoctor – предоставление профессиональной информации врачам, провизорам и фармацевтам.